These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 16473668

  • 1. FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.
    Zhou C, Ling MT, Kin-Wah Lee T, Man K, Wang X, Wong YC.
    Cancer Lett; 2006 Feb 20; 233(1):36-47. PubMed ID: 16473668
    [Abstract] [Full Text] [Related]

  • 2. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
    Chua CW, Chiu YT, Yuen HF, Chan KW, Man K, Wang X, Ling MT, Wong YC.
    Clin Cancer Res; 2009 Jul 01; 15(13):4322-35. PubMed ID: 19509141
    [Abstract] [Full Text] [Related]

  • 3. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells.
    Shen Y, Cai M, Xia W, Liu J, Zhang Q, Xie H, Wang C, Wang X, Zheng S.
    Cancer Lett; 2007 Sep 08; 254(2):288-97. PubMed ID: 17462818
    [Abstract] [Full Text] [Related]

  • 4. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O.
    Cancer Res; 2010 Nov 01; 70(21):8651-61. PubMed ID: 20959468
    [Abstract] [Full Text] [Related]

  • 5. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models.
    Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, Morimoto J, Fukui R, Hoshiga M, Ishihara T, Nonomura N, Suzuki S, Okuyama A, Katsuoka Y.
    Cancer Res; 2002 Mar 01; 62(5):1410-9. PubMed ID: 11888913
    [Abstract] [Full Text] [Related]

  • 6. Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
    Bonaccorsi L, Marchiani S, Ferruzzi P, Muratori M, Crescioli C, Forti G, Maggi M, Baldi E.
    Steroids; 2006 Apr 01; 71(4):304-9. PubMed ID: 16289173
    [Abstract] [Full Text] [Related]

  • 7. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y.
    Anticancer Res; 2007 Apr 01; 27(1A):75-88. PubMed ID: 17352219
    [Abstract] [Full Text] [Related]

  • 8. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
    Yi L, Zhang QY, Mi MT.
    Ai Zheng; 2007 Dec 01; 26(12):1281-6. PubMed ID: 18076787
    [Abstract] [Full Text] [Related]

  • 9. FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer.
    Chua CW, Lee DT, Ling MT, Zhou C, Man K, Ho J, Chan FL, Wang X, Wong YC.
    Int J Cancer; 2005 Dec 20; 117(6):1039-48. PubMed ID: 15986440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM.
    Prostate; 2007 Jul 01; 67(10):1081-90. PubMed ID: 17476687
    [Abstract] [Full Text] [Related]

  • 13. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression.
    Chu Q, Ling MT, Feng H, Cheung HW, Tsao SW, Wang X, Wong YC.
    Carcinogenesis; 2006 Nov 01; 27(11):2180-9. PubMed ID: 16675472
    [Abstract] [Full Text] [Related]

  • 14. [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].
    Liu SJ, Xu KX, Wang XF, Hou SK, Wang YC.
    Zhonghua Wai Ke Za Zhi; 2004 May 22; 42(10):604-6. PubMed ID: 15265404
    [Abstract] [Full Text] [Related]

  • 15. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
    Zheng R, Iwase A, Shen R, Goodman OB, Sugimoto N, Takuwa Y, Lerner DJ, Nanus DM.
    Oncogene; 2006 Sep 28; 25(44):5942-52. PubMed ID: 16652149
    [Abstract] [Full Text] [Related]

  • 16. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL, Festuccia C, Millimaggi D, Dolo V, Tombolini V, de Vito M, Vicentini C, Bologna M.
    Prostate; 2008 May 15; 68(7):793-801. PubMed ID: 18324645
    [Abstract] [Full Text] [Related]

  • 17. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer.
    Howard EW, Ling MT, Chua CW, Cheung HW, Wang X, Wong YC.
    Clin Cancer Res; 2007 Mar 15; 13(6):1847-56. PubMed ID: 17363541
    [Abstract] [Full Text] [Related]

  • 18. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP.
    Ann Neurol; 2008 Jan 15; 63(1):61-71. PubMed ID: 17918267
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines.
    Xu K, Wang X, Ling M, Wong Y.
    Chin Med J (Engl); 2003 Nov 15; 116(11):1673-7. PubMed ID: 14642133
    [Abstract] [Full Text] [Related]

  • 20. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
    Darnel AD, Behmoaram E, Vollmer RT, Corcos J, Bijian K, Sircar K, Su J, Jiao J, Alaoui-Jamali MA, Bismar TA.
    Clin Cancer Res; 2009 Feb 15; 15(4):1376-83. PubMed ID: 19228738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.